1290 AVENUE OF THE AMERICAS,
NEW YORK , NY, 10104

Rank

Rank Universe

Summary

The fund seeks to appreciate capital through investing in foreign companies in the developed and emerging markets.

The investment process starts with companies with market capitalization of more than $2.5 billion and then applies financial screens to narrow the list of stocks that are lagging their estimated long term valuation.

The research team then considers local and regional market conditions, political climate and bus More

Link

Directors

Nov 7, 2023
  • Ami Kaplan
  • George W. Morriss
  • Joseph V. Amato
  • Deborah C. Mclean
  • James G. Stavridis
  • Michael M. Knetter
  • Franklyn E. Smith
  • Michael J. Cosgrove
  • Tom D. Seip
  • Marc Gary
  • Martha C. Goss

Chief Compliance Officer

  • Savonne L. Ferguson

Fund Manager(s)

Price

  • $ 13.88 ( +0.06 )
    Nov 1, 2024
    Last Close
  • Net Assets
  • $147M
    Jan 26, 2024
  • Holding
  • 85
    Jul 29, 2024
    More

  • 52-Week High/Low
  • $14.84 - $11.79
  • Turnover
  • 50%
  • Expense Ratio
  • 0.98%

Company Name

Holding

ASML Holding NV 3.49 %
AstraZeneca PLC 2.43 %
Experian PLC 2.09 %
Hitachi Ltd 2.07 %
London Stock Exchange Group PLC 1.97 %
RELX PLC 1.96 %
Novo Nordisk A/S 1.8 %
BAE Systems PLC 1.8 %
Shell PLC 1.77 %
Symrise AG 1.73 %
More 1.73 %

Documents

Prospectus

Annual Reports

Performance

YTD

2.3%

3 Year

-20.09%

5 Year

5.31%

Best

34.14%

2009

Worst

-43.03%

2008

Alpha

NILIX S&P 500

Chart +